SCHEMBL30189206

SCHEMBL30189206

O=C(O)c1cc2c(F)cccc2[nH]1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 2/20 0.60
KDM4E B2RXH2 4/20 0.59
HSD17B10 Q99714 4/20 0.59
ALDH1A1 P00352 3/20 0.59
HPGD P15428 3/20 0.59
CYP2C19 P33261 2/20 0.59
MEN1 O00255 1/20 0.59
GRIN2D O15399 1/20 0.59
GRIN3B O60391 1/20 0.59
CYP1A2 P05177 1/20 0.59
GLA P06280 1/20 0.59
GAA P10253 1/20 0.59
MAPK1 P28482 1/20 0.59
AHR P35869 1/20 0.59
CHRNA7 P36544 1/20 0.59
KMT2A Q03164 1/20 0.59
GRIN1 Q05586 1/20 0.59
GRIN2A Q12879 1/20 0.59
GRIN2B Q13224 1/20 0.59
GRIN2C Q14957 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3417091 1.00 FLT3 (0.60) FLT3KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL8249945 0.88 FLT3 (0.55) FLT3KDM4EHSD17B10ALDH1A1HPGD
Trifluoroacetamide SCHEMBL8206818 0.87 FLT3 (0.49) FLT3KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL16234660 0.86 HRH4 (0.59) FLT3KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL15511675 0.86 FLT3 (0.57) FLT3KDM4EHSD17B10ALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL8206820 0.84 ALB (0.47) FLT3KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL14765166 0.82 KDM4E (0.58) FLT3KDM4EALDH1A1GAAMAPK1
SCHEMBL2323348 0.82 FLT3 (0.59) FLT3CYP1A2GLAGAAHRH4
SCHEMBL30147706 0.82 HRH4 (0.56) FLT3GAAHRH4DAODDO
SCHEMBL18900657 0.82 HRH4 (0.56) FLT3HRH4DAODDOEIF4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587433-A1 3-(1H-INDOLE-2-CARBONYL)-6,6-DIMETHYL-N-((S)-1-OXO-3-((S)-2-OXOPYRROLIDIN-3-YL)P ROPAN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE DERIVATIVES AS MPRO INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS Takeda Pharmaceutical Company Limited (JP) 2025-07-23 EP disclosed
WO-2024059087-A1 3-(1H-INDOLE-2-CARBONYL)-6,6-DIMETHYL-N-((S)-1-OXO-3-((S)-2-OXOPYRROLIDIN-3-YL)P ROPAN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE DERIVATIVES AS MPRO INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-03-21 WO disclosed
EP-4161916-A1 SUBSTITUTED ISOQUINOLINYLMETHYL AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2023-04-12 EP disclosed
EP-4149945-A1 SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2023-03-22 EP disclosed
WO-2023022231-A1 REVERSIBLE COVALENT BINDING INHIBITOR FOR TREATING OR PREVENTING VIRAL INFECTION 国立大学法人九州大学 2023-02-23 WO disclosed